Meeting
2018 Genitourinary Cancers Symposium
Post-chemotherapy PD-L1 expression correlates with clinical outcomes in Japanese bladder cancer patients treated with total cystectomy.
Authors
Yasuhiro Hashimoto
Hirosaki University Graduate School of Medicine, Hirosaki, Japan
Yasuhiro Hashimoto , Daisuke Noro , Shingo Hatakeyama , Takahiro Yoneyama , Takuya Koie , Toshiaki Kawaguchi , Chikara Ohyama
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral, and Testicular Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 416)
DOI
10.1200/JCO.2018.36.6_suppl.416
Abstract #
416
Poster Bd #
F9
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Expression of Nectin-4 and PD-L1 in bladder cancer with variant histology.
First Author: Katherine Case
Poster
2021 ASCO Annual Meeting
PD-L1 expression and TOP3A mutation as prognostic factors for adjuvant chemotherapy in triple negative breast cancer.
First Author: Xue Wang
Poster
2020 Genitourinary Cancers Symposium
Feasibility of finding circulating tumors cells and assigning PD-L1 receptor status using single-cell technology combined with Celsee Genesis system.
First Author: Shaheen Riadh Alanee
Poster
2019 ASCO Annual Meeting
PD-L1/PD-1 expression as a predictor of response to BCG in patients with high-risk non–muscle invasive bladder cancer.
First Author: Mathieu Roumiguie